Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality

被引：0

作者：

Calderon-Cabrera, Cristina ^{[1
]}

Falantes, Jose F. ^{[1
]}

Bernal, Ricardo ^{[1
]}

Perez-Simon, Jose A. ^{[1
]}

机构：

[1] Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Serv Hematol,Hosp Univ Virgen del Rocio, Seville, Spain

来源：

MEDICINA CLINICA | 2015年 / 145卷 / 05期

关键词：

CONVENTIONAL CARE REGIMENS; SCORING SYSTEM; AZACITIDINE; PROGNOSIS; SURVIVAL; MDS;

D O I：

10.1016/j.medcli.2014.07.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：224 / 226

页数：3

共 10 条

[1] 5′-Azacitidine in myelodysplastic syndromes with inversion of chromosome 3 [J].

Breccia, M. ;

Cannella, L. ;

Santopietro, M. ;

Loglisci, G. ;

Federico, V. ;

Salaroli, A. ;

Nanni, M. ;

Mancini, M. ;

Alimena, G. .

LEUKEMIA, 2011, 25 (04) :736-737

[2] Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Gattermann, Norbert ;

Germing, Ulrich ;

Sanz, Guillermo ;

List, Alan F. ;

Gore, Steven ;

Seymour, John F. ;

Dombret, Herve ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :562-569

[3] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Finelli, Carlo ;

Giagounidis, Aristoteles ;

Schoch, Robert ;

Gattermann, Norbert ;

Sanz, Guillermo ;

List, Alan ;

Gore, Steven D. ;

Seymour, John F. ;

Bennett, John M. ;

Byrd, John ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

LANCET ONCOLOGY, 2009, 10 (03) :223-232

[4] A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial [J].

Gore, Steven D. ;

Fenaux, Pierre ;

Santini, Valeria ;

Bennett, John M. ;

Silverman, Lewis R. ;

Seymour, John F. ;

Hellstrom-Lindberg, Eva ;

Swern, Arlene S. ;

Beach, Charles. L. ;

List, Alan. F. .

HAEMATOLOGICA, 2013, 98 (07) :1067-1072

[5] Revised International Prognostic Scoring System for Myelodysplastic Syndromes [J].

Greenberg, Peter L. ;

Tuechler, Heinz ;

Schanz, Julie ;

Sanz, Guillermo ;

Garcia-Manero, Guillermo ;

Sole, Francesc ;

Bennett, John M. ;

Bowen, David ;

Fenaux, Pierre ;

Dreyfus, Francois ;

Kantarjian, Hagop ;

Kuendgen, Andrea ;

Levis, Alessandro ;

Malcovati, Luca ;

Cazzola, Mario ;

Cermak, Jaroslav ;

Fonatsch, Christa ;

Le Beau, Michelle M. ;

Slovak, Marilyn L. ;

Krieger, Otto ;

Luebbert, Michael ;

Maciejewski, Jaroslaw ;

Magalhaes, Silvia M. M. ;

Miyazaki, Yasushi ;

Pfeilstoecker, Michael ;

Sekeres, Mikkael ;

Sperr, Wolfgang R. ;

Stauder, Reinhard ;

Tauro, Sudhir ;

Valent, Peter ;

Vallespi, Teresa ;

van de Loosdrecht, Arjan A. ;

Germing, Ulrich ;

Haase, Detlef .

BLOOD, 2012, 120 (12) :2454-2465

[6] The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML [J].

Haferlach, C. ;

Bacher, U. ;

Haferlach, T. ;

Dicker, F. ;

Alpermann, T. ;

Kern, W. ;

Schnittger, S. .

LEUKEMIA, 2011, 25 (05) :874-877

[7] Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases [J].

Haferlach, Claudia ;

Bacher, Ulrike ;

Grossmann, Vera ;

Schindela, Sonja ;

Zenger, Melanie ;

Kohlmann, Alexander ;

Kern, Wolfgang ;

Haferlach, Torsten ;

Schnittger, Susanne .

GENES CHROMOSOMES & CANCER, 2012, 51 (12) :1079-1085

[8] Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia [J].

Lugthart, Sanne ;

Groschel, Stefan ;

Beverloo, H. Berna ;

Kayser, Sabine ;

Valk, Peter J. M. ;

van Zelderen-Bhola, Shama Lydia ;

Ossenkoppele, Gert Jan ;

Vellenga, Edo ;

van den Berg-de Ruiter, Eva ;

Schanz, Urs ;

Verhoef, Gregor ;

Vandenberghe, Peter ;

Ferrant, Augustin ;

Kohne, Claus-Henning ;

Pfreundschuh, Michael ;

Horst, Heinz A. ;

Koller, Elisabeth ;

von Lilienfeld-Toal, Marie ;

Bentz, Martin ;

Ganser, Arnold ;

Schlegelberger, Brigitte ;

Jotterand, Martine ;

Krauter, Jurgen ;

Pabst, Thomas ;

Theobald, Matthias ;

Schlenk, Richard F. ;

Delwel, Ruud ;

Dohner, Konstanze ;

Lowenberg, Bob ;

Doehner, Hartmut .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (24) :3890-3898

[9] New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge [J].

Schanz, Julie ;

Tuechler, Heinz ;

Sole, Francesc ;

Mallo, Mar ;

Luno, Elisa ;

Cervera, Jose ;

Granada, Isabel ;

Hildebrandt, Barbara ;

Slovak, Marilyn L. ;

Ohyashiki, Kazuma ;

Steidl, Christian ;

Fonatsch, Christa ;

Pfeilstoecker, Michael ;

Noesslinger, Thomas ;

Valent, Peter ;

Giagounidis, Aristoteles ;

Aul, Carlo ;

Luebbert, Michael ;

Stauder, Reinhard ;

Krieger, Otto ;

Garcia-Manero, Guillermo ;

Faderl, Stefan ;

Pierce, Sherry ;

Le Beau, Michelle M. ;

Bennett, John M. ;

Greenberg, Peter ;

Germing, Ulrich ;

Haase, Detlef .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :820-829

[10] High EVI1 expression predicts poor survival in acute myeloid leukemia:: a study of 319 de novo AML patients [J].

van Doorn-Khosrovani, SBV ;

Erpelinck, C ;

van Putten, WLJ ;

Valk, PJM ;

de Luytgaarde, SV ;

Hack, R ;

Slater, R ;

Smit, EME ;

Beverloo, HB ;

Verhoef, G ;

Verdonck, LF ;

Ossenkoppele, GJ ;

Sonneveld, P ;

de Greef, GE ;

Löwenberg, B ;

Delwel, R .

BLOOD, 2003, 101 (03) :837-845

← 1 →